Robert Kesterson, PhD — CRISPRS & Gene Editing: Laboratory Use & Clinical Future (SERN/SERGG 2017)
Invited Speaker: Robert A. Kesterson, PhD – UAB “CRISPRs & Gene Editing: Laboratory Use & Clinical Future”
Christine Eng, MD — Clinical Whole Exome Sequencing For the Evaluation of Genetic Disorders (SERN/SERGG 2013)
Dr. Eng presents on whole exome sequencing.
Clinical Application of Microarray Technology on Hematological Malignancies and Solid Tumor: The CCMC Experience
Dr. Li presents at the 2010 SERGG Annual Meeting.
Basic Building Blocks for Biomedical Ontologies
Dr. Barry Smith presents on biomedical ontology. This is the second in a two-part series.
Stuart Shapira, MD, PhD — Routine Second Testing in Newborn Screening for Hypothyroidism and Congenital Adrenal Hyperplasia: Is One Screening Test Sufficient? (SERN/SERGG 2012)
Dr. Shapira presents on Newborn Screening for Hypothyroidism and Congenital Adrenal Hyperplasia.
Emily Lisi, MS, CGC — The Current Status of Direct-to-Consumer Genetic Testing (SERN/SERGG 2017)
Invited Speaker: Emily Lisi, MS, CGC – Mayo Clinic “The Current Status of Direct-to-Consumer Genetic Testing”
The Exciting World of Genetics in India – From Clinical to Chromosomes, and Metabolic to Molecular
Dr. Verma presents on genetics in India.
Muin Khoury, MD, PhD — The Scientific Foundation for Using Personal Genomics to Improve Health and Prevent Disease (SERN/SERGG 2011)
Dr. Khoury presents at the 2011 SERC-SERGG Annual Conference.
ISCA (International Standards for Cytogenomic Arrays)
Dr. Ledbetter presents at the 2010 SERGG Annual Meeting.
How to Build Useful Ontologies for Clinical and Translational Research
Dr. Barry Smith presents on biomedical ontology. This is the first of a two-part lecture.
Issues in Genetic Testing in Navajo Populations
Dr. Brilliant presents at the 2010 SERGG Annual Meeting.
Hutton Kearney, PhD, FACMG — Navigating uncertainty and unexpected findings in whole genome array testing: A discussion of interpretation and reporting strategies (SERN/SERGG 2013)
Dr. Kearney presents on genome array testing.
Kristy Lee, CGC, MS — Challenges in Interpretation & Explanation of Exome Sequencing (SERN/SERGG 2015)
Ms. Kristy Lee presents, Challenges in Interpretation & Explanation of Exome Sequencing.
David Bick, MD — Whole Genome Sequencing – It’s Time Has Arrived (SERN/SERGG 2016)
Dr. Bick presents, “Whole Genome Sequencing – It’s Time Has Arrived”
Michael Watson, PhD, MS, FACMG — LTDs and the FDA (SERN/SERGG 2016)
Dr. Watson presents, “LTDs and the FDA”
Deeksha Bali, PhD, FACMG — Diagnostic confirmation of Pompe Disease: experience of a clinical laboratory (SERN/SERGG 2015)
Dr. Bali presents Diagnostic confirmation of Pompe Disease: experience of a clinical laboratory.